Clinical Trial Update: Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome [Phase 3]

View source ↗

Summary

Ongoing Phase 3 clinical trial evaluating glepaglutide for Short Bowel Syndrome; enrollment is by invitation in multiple sites.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Glepaglutide (glepaglutide)

Snippet

Sponsor: Zealand Pharma | Conditions: Short Bowel Syndrome (SBS) | Phase 3 | Status: ENROLLING_BY_INVITATION